Papers: 10.1007/s00384-017-2800-1

https://doi.org/10.1007/s00384-017-2800-1

Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma

Cited by: 91
Author(s): Fernando Rivera, Meinolf Karthaus, J. Randolph Hecht, Isabel Sevilla, Fréd́eric Forget, Gianpiero Fasola, Jean-Luc Canon, Xiaodan Guan, Gaston Demonty, Lee S. Schwartzberg
Published: over 9 years ago

Software Mentions 1